The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCharacter Regulatory News (CCT)

Share Price Information for Character (CCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 277.00
Bid: 274.00
Ask: 280.00
Change: 0.00 (0.00%)
Spread: 6.00 (2.19%)
Open: 277.00
High: 278.00
Low: 277.00
Prev. Close: 277.00
CCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

26 Sep 2014 07:00

RNS Number : 6791S
Character Group PLC
26 September 2014
 



26 September 2014

 

The Character Group plc

("Character Group" or the "Company")

 

Exercise of share options and dealing in ordinary shares by Directors

Transaction in Company's own shares

Grant of options to an executive Director

 

Character Group (AIM: CCT) announces that yesterday it received notification from certain executive Directors of the Company of the exercise by them of share options granted to them under the Company's 2006 Share Option Plan (the "Plan") and the subsequent sale of certain of such shares, as follows:

· Richard King, Chairman, has exercised options in respect of a total of 362,999 Ordinary Shares of 5p each in the Company ("Ordinary Shares"); 203,000 at an exercise price of 63p per share and 159,999 at an exercise price of 35.5p per share. He subsequently sold 362,999 of such Ordinary Shares in the market at a price of 213 per share.

· Kiran Shah, Group Finance Director and Joint Managing Director, has exercised options in respect of a total of 362,999 Ordinary Shares; 203,000 at an exercise price of 63p per share and 159,999 at an exercise price of 35.5p per share. He subsequently sold 240,999 of such Ordinary Shares in the market at a price of 213p per share.

· Jonathan Diver, Group Marketing Director and Joint Managing Director, has exercised options in respect of a total of 483,000 Ordinary Shares; 183,000 at an exercise price of 63p per share and 300,000 at an exercise price of 35.5p per share. He subsequently sold 303,000 of such Ordinary Shares in the market at a price of 213p per share.

· Joseph Kissane, Managing Director of Character Options Limited, has exercised options in respect of a total of 483,000 Ordinary Shares; 183,000 at an exercise price of 63p per share and 300,000 at an exercise price of 35.5p per share. He subsequently sold 483,000 of such Ordinary Shares in the market at a price of 213p per share.

Accordingly, a total of 1,691,998 Ordinary Shares (the "Option Shares") were allotted to these Directors by the Company on 25 September 2014, to satisfy such option exercises. The Option Shares rank pari passu with the existing issued Ordinary Shares. The Option Shares have been admitted to trading on the AIM market of the London Stock Exchange plc pursuant to an existing block listing.

In continuation of the buy-back programme conducted by the Company in recent years, the Company announces that yesterday, 25 September 2014, it acquired 1,425,972 Ordinary Shares for cancellation at a price of 213p per share, representing approximately 6.18 per cent. of the issued share capital of the Company (taking into account the issue of the Option Shares but excluding shares held in treasury). This purchase includes 1,321,998 of the Option Shares sold yesterday by Richard King, Kiran Shah, Jonathan Diver and Joseph Kissane. The participation by executive Directors in the buy-back programme is deemed to be a related party transaction for the purposes of Rule 13 of the AIM Rules for Companies. The Directors of the Company, with the exception of Richard King, Kiran Shah, Jonathan Diver and Joseph Kissane, having consulted with Charles Stanley Securities (the Company's Nominated Adviser), consider that the participation of the relevant executive Directors in the buy-back programme to be fair and reasonable insofar as the Company's shareholders are concerned.

For the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules, the total number of Ordinary Shares in issue as at the date of this notice (taking into account the issue of the Option Shares and the purchase of Ordinary Shares for cancellation by the Company announced above but excluding Ordinary Shares held in treasury) is 21,651,684 ("Revised Issued Voting Share Capital").

 

The Company has also been notified that Michael Hyde, Managing Director of Character Group's Far East Operations, yesterday purchased 28,000 Ordinary Shares at a price of 213p per share, representing approximately 0.13 per cent. of the Revised Issued Voting Share Capital.

Following the above mentioned exercise of share options, the sale of Option Shares and purchase of Ordinary Shares, the interests of the Directors in the Revised Issued Voting Share Capital are as follows:

 

Director

Exercise of Share Options

Sale of Option Shares

Purchase of Ordinary Shares

Directors' resulting interests

approx. % of RevisedIssued VotingShare Capital

Richard King1

362,999

362,999

-

2,418,210

11.17%

Kiran Shah2

362,999

240,999

-

4,117,001

19.01%

Jonathan Diver3

483,000

303,000

-

1,206,003

5.57%

Joseph Kissane

483,000

483,000

-

500,000

2.31%

Michael Hyde

-

-

28,000

200,000

0.92%

Orbis Pension Trustees Limited4

-

-

-

285,000

1.32%

David Harris

-

-

-

44,097

0.20%

Lord Birdwood

-

-

-

8,750

0.04%

 

Notes:

1. included in the interests of R. King are his interests in 1,635,428 Ordinary Shares held by Cedarberg Investments Limited.

2. included in the interests of K.P. Shah are the interests of Sarissa Holdings Limited in 3,830,000 Ordinary Shares.

3. included in the interests of J.J. Diver are 551,867 Ordinary Shares held by Mr Diver's personal pension scheme;

4. Orbis Pension Trustees Limited is the trustee of the Company's Employee Share Ownership Trust. Each of R. King, K.P. Shah, J.J.P. Kissane, J.J. Diver and M.S.Hyde is deemed to be interested in such Ordinary Shares by virtue of being within the class of beneficiaries defined by such trust.

 

The Company also announces that, upon the recommendation of the Company's Remuneration Committee, the Board yesterday granted Michael Hyde an option over a total of 100,000 Ordinary Shares (the "Option"), representing approximately 0.46 per cent. of the Revised Issued Voting Share Capital. The Options are exercisable at 213 pence per ordinary share, being the average closing mid-market price of an Ordinary Share on the three business days prior to the grant. The Options will vest, subject to satisfaction of certain conditions, on the third anniversary of the date of grant.

Character Group holds 4,019,456 Ordinary Shares in treasury, representing approximately 18.56 per cent. of the Revised Issued Voting Share Capital, which do not carry voting rights.

 

The figure of 21,651,684 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or change to their interest, in the Company under the Disclosure and Transparency Rules.

 

 

 

Enquiries:

Kiran Shah, Group Finance Director & Joint MD

Fiona Tooley

Russell Cook

Mark Dowding, Company Secretary

IR & Media Relations

Carl Holmes

The Character Group plc

Tooley Street Communications

Charles Stanley Securities

Tel: +44 (0)208 329 3377

Tel: +44 (0)7785 703 523

(Nominated Adviser & Broker)

Tel: +44 (0)207 149 6000

Ticker: AIM: CCT

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSFQLBLZKFZBBX
Date   Source Headline
29th Apr 20245:47 pmRNSTransaction in Own Shares
26th Apr 20247:00 amRNSHolding(s) in Company
12th Apr 20246:16 pmRNSTransaction in Own Shares
11th Apr 20245:23 pmRNSTransaction in Own Shares
9th Apr 20245:25 pmRNSTransaction in Own Shares
8th Apr 20245:49 pmRNSTransaction in Own Shares
4th Apr 20245:44 pmRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSExtension of & increase to Share Buyback Programme
13th Mar 20245:19 pmRNSTransaction in Own Shares
7th Mar 20245:55 pmRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20245:03 pmRNSTransaction in Own Shares
27th Feb 20245:03 pmRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20245:20 pmRNSTransaction in Own Shares
22nd Feb 20245:59 pmRNSTransaction in Own Shares
21st Feb 20245:03 pmRNSTransaction in Own Shares
19th Feb 20246:08 pmRNSTransaction in Own Shares
19th Feb 202412:07 pmRNSHolding(s) in Company
19th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20246:13 pmRNSTransaction in Own Shares
14th Feb 20245:38 pmRNSTransaction in Own Shares
13th Feb 20245:49 pmRNSTransaction in Own Shares
9th Feb 20244:19 pmRNSTransaction in Own Shares
8th Feb 20245:44 pmRNSTransaction in Own Shares
7th Feb 202410:20 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSShare Buyback Programme
19th Jan 20244:41 pmRNSResult of AGM
19th Jan 20247:00 amRNSAGM Statement - Trading Update
14th Dec 202312:53 pmRNSHolding(s) in Company
14th Dec 202312:49 pmRNSHolding(s) in Company
12th Dec 20237:01 amRNSFinal Results - year ended 31 August 2023
12th Dec 20237:00 amRNSBoard Changes
23rd Oct 20234:58 pmRNSDirector/PDMR Shareholding
3rd Oct 20237:00 amRNSTrading Update
22nd Sep 20234:08 pmRNSHolding(s) in Company
20th Sep 20235:30 pmRNSHolding(s) in Company
22nd Aug 20237:00 amRNSHolding(s) in Company
31st Jul 20237:00 amRNSDirector/PDMR Shareholding
17th May 202311:32 amRNSDirector/PDMR Shareholding
15th May 20237:00 amRNSDirector/PDMR Shareholding
15th May 20237:00 amRNSHolding(s) in Company
11th May 20237:00 amRNSHalf-year Report - six months to 28 February 2023
27th Mar 20236:00 pmRNSHolding(s) in Company
20th Jan 20234:41 pmRNSResult of AGM
20th Jan 20237:00 amRNSTrading update ahead of the AGM
28th Dec 20227:34 amRNSDirector's share dealings, Treasury shares and TVR
22nd Dec 20224:40 pmRNSSecond Price Monitoring Extn
22nd Dec 20224:35 pmRNSPrice Monitoring Extension
22nd Dec 20227:00 amRNSAUDITED ANNUAL RESULTS -YEAR ENDED 31 AUGUST 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.